Skip to main
AVNT

Avient Corp (AVNT) Stock Forecast & Price Target

Avient Corp (AVNT) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 43%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Avient Corp has experienced a notable organic sales increase of 5%, indicating solid performance across its segments. The healthcare sales segment has shown remarkable resilience, achieving double-digit growth for six consecutive quarters and a significant year-over-year increase of 14% in the first half of 2025. Additionally, four out of nine end markets, which collectively account for 40% of Avient's sales, are expanding, contributing to an overall organic sales growth of approximately 2% for 2025.

Bears say

Avient Corp has registered a decline in organic sales, reporting a drop of approximately 2% in the first quarter of 2024, despite experiencing a recovery with 5% year-over-year growth in the subsequent quarters. Additionally, the company faces weakening demand in the chemicals sector, with forecasts indicating potential downside risks to volumes in the second half of 2025. While a declining dollar may provide a temporary benefit, the overall negative trends in sales and demand raise concerns about the company's financial stability moving forward.

Avient Corp (AVNT) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Avient Corp (AVNT) Forecast

Analysts have given Avient Corp (AVNT) a Buy based on their latest research and market trends.

According to 7 analysts, Avient Corp (AVNT) has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $45.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $45.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Avient Corp (AVNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.